---
title: "Eli Lilly and Company"
symbol: "LLY"
market_cap: "Mega Cap ($200B+)"
risk_level: "Low Risk"
sector: "Healthcare"
industry: "Pharmaceuticals"
description: "Global pharmaceutical company focused on innovative medicines"
highlights:
  - "Leader in diabetes and obesity treatments"
  - "Strong pipeline of new drugs"
  - "Consistent dividend history"
  - "Growing presence in immunology"
key_stats:
  pe_ratio: "~110"
  dividend_yield: "~0.8%"
  beta: "0.35"
--- 